Nurix Therapeutics, Inc. NRIX
Set alert
25.70 USD 0.00 0.00%
At close
25.46 -0.24 -0.93%
Pre-market · Nov 3, 8:57 AM ET
25.53 Day range 26.96
11.67 52-week range 28.23
- YTD
- +35.48%
- 1 year
- +103.65%
- Open
- 26.75
- Prev close
- 25.70
- Mkt cap
- 2.81B
- Vol
- 2.35M
- Avg vol
- 1.74M
- EPS
- 2.43
- P/E
- 10.58
- Div yield
- 0.00%
More statistics
- Low
- 25.53
- High
- 26.96
- Forward P/E
- -20.15
- Beta
- 1.78
- Short ratio
- 10.30
- Inst. own
- 111.03%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 27, 2027
- 50-d avg
- 24.98
- 200-d avg
- 20.18
- 1y target
- 34.50
5Y chart
Events in this range
- Oct 9, 2025Earnings: -1.03; estimate -0.84; surprise -22.62%
- Jan 28, 2026Earnings: -0.82; estimate -0.84; surprise 2.38%
- Apr 8, 2026Earnings: -0.79; estimate -0.76; surprise -3.95%
- Jul 9, 2026Earnings: -0.81; estimate -0.72288; surprise -12.05%
- Oct 12, 2026Earnings: 4.73; estimate -0.60091; surprise 887.14%
- Oct 13, 2026Rating: Needham · Buy → Buy
- Oct 13, 2026Rating: Baird · Outperform → Outperform
- Oct 13, 2026Rating: Truist Securities · Buy → Buy
- Oct 13, 2026Rating: Oppenheimer · Outperform → Outperform
- Oct 13, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 16, 2026Rating: HC Wainwright & Co. · Buy → Buy
Signals (80)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| RSI: Overbought | Aug 3, 2026 | 3 months ago |
| RSI: Overbought | Jun 29, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | May 25, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| SMA: Bullish | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| MACD: Sell Signal | Feb 9, 2026 | 8 months ago |
Newest 20 of 80.
Analyst view
Consensus: none
Price target (mean) 34.50 +34.2% upside
Now 25.70
- Target (low)
- 25.00
- Target (mean)
- 34.50
- Target (high)
- 45.00
Ratings (0m) 14 13 buy · 1 hold · 0 sell
- Strong buy5
- Buy8
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.51 | -0.64 – 5.26 | -0.82 | +283.9% | 287.86M | +2020.2% | 3 |
| Next quarter | -0.59 | -0.59 – -0.59 | -0.79 | +25.3% | 15.00M | +139.9% | 1 |
| Current year | 3.02 | 2.96 – 3.10 | -3.05 | +199.0% | 744.85M | +786.9% | 3 |
| Next year | -1.28 | -2.48 – -0.62 | 3.02 | -142.2% | 123.22M | -83.5% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 16, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 13, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 13, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 13, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 13, 2026 | Baird | Maintained | Outperform | Outperform |
| Oct 13, 2026 | Needham | Reiterated | Buy | Buy |
| Aug 10, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 4, 2026 | Needham | Reiterated | Buy | Buy |
| Jul 28, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 22, 2026 | UBS | Maintained | Buy | Buy |
| Jul 13, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 10, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 10, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 10, 2026 | Stifel | Maintained | Buy | Buy |
| Jul 10, 2026 | BTIG | Reiterated | Buy | Buy |
| Jul 10, 2026 | Needham | Reiterated | Buy | Buy |
| Jul 10, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 18, 2026 | Baird | Maintained | Outperform | Outperform |
| Jun 15, 2026 | Needham | Reiterated | Buy | Buy |
| Jun 10, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 9, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jun 9, 2026 | BTIG | Maintained | Buy | Buy |
| Jun 8, 2026 | Jefferies | Maintained | Buy | Buy |
| Jun 8, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jun 8, 2026 | Needham | Maintained | Buy | Buy |
| May 18, 2026 | BTIG | Reiterated | Buy | Buy |
| Apr 27, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 23, 2026 | Needham | Reiterated | Buy | Buy |
| Apr 10, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 9, 2026 | Wells Fargo | Maintained | Overweight | Overweight |